REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00663416

Locations


Canada, Alberta
	Department of Clinical Neurosciences, Univeristy of Calgary
	Calgary, Alberta, Canada, T2N 2T9
	Chinook Regional Hospital
	Lethbridge, Alberta, Canada, T1J 1W5
	Walter Mackenzie Health Sciences Centre
	Edmonton, Alberta, Canada, T6G 2B7
	Grey Nuns Community Hospital
	Edmonton, Alberta, Canada, T6L 5X3

Canada, British Columbia
	Vancouver General Hospital
	Vancouver, British Columbia, Canada, V5Z 1M9
	Vancouver Island Health Research Centre
	Victoria, British Columbia, Canada, V8R 1J8
	Penticton Regional Hospital
	penticton, British Columbia, Canada, V2A 3G6

Canada, Manitoba
	Brandon Regional Health Centre
	Brandon, Manitoba, Canada, R7A 2B3

Canada, Nova Scotia
	Queen Elizabeth II Health Sciences Centre
	Halifax, Nova Scotia, Canada, B3H 3A7

Canada, Ontario
	Trillium Health Centre
	Mississauga, Ontario, Canada, L5B 1B8
	Division of Neurology , Sunnybrook Health Sciences Centre
	Toronto, Ontario, Canada, M4N 3M5
	Department of Neurology, St. Michael's Hospital
	Toronto, Ontario, Canada, M5B 1W8
	University Health Network
	Toronto, Ontario, Canada, M5T 2S8
	Thunder Bay Regional Health Sciences Centre
	Thunder Bay, Ontario, Canada, P7B 6V4
	McMaster Clinic
	Hamilton, Ontario, Canada, L8L 2X2

Canada, Quebec
	Montreal Neurological Institute
	Montreal, Quebec, Canada, H3A 2B4

Sponsors and Collaborators

Stem Cell Therapeutics Corp.

Investigators


Principal Investigator:	Michael D Hill, MD	Department of Clinical Neurosciences, University of Calgary

Principal Investigator:	Steven C Cramer, MD	Department of Neurology, University of Califonia, Irvine Medical Center